Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of subsequent treatment for unresectable locally-advanced non-small cell lung cancer after relapse of concurrent chemoradiotherapy with durvalumab consolidation therapy: A single-center retrospective study.
Nishibori Y, Kenmotsu H, Ando K, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Morikawa N, Miura K, Kodama H, Yabe M, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Harada H, Takahashi T. Nishibori Y, et al. Among authors: iida y. Cancer Treat Res Commun. 2024 Nov 8;41:100849. doi: 10.1016/j.ctarc.2024.100849. Online ahead of print. Cancer Treat Res Commun. 2024. PMID: 39536390 Free article.
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second-line chemotherapy in patients with small cell lung cancer.
Sekikawa M, Murakami H, Morita M, Doshita K, Miura K, Kodama H, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Kenmotsu H, Naito T, Chiba H, Takahashi T. Sekikawa M, et al. Among authors: iida y. Thorac Cancer. 2023 Dec;14(35):3475-3482. doi: 10.1111/1759-7714.15140. Epub 2023 Oct 24. Thorac Cancer. 2023. PMID: 37873674 Free PMC article.
Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study.
Morikawa N, Naito T, Morita M, Sekikawa M, Doshita K, Yabe M, Kodama H, Miura K, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Kenmotsu H, Murakami H, Takahashi T. Morikawa N, et al. Among authors: iida y. J Geriatr Oncol. 2024 Sep;15(7):101832. doi: 10.1016/j.jgo.2024.101832. Epub 2024 Jul 12. J Geriatr Oncol. 2024. PMID: 38997933 Free article.
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Morita M, Ono A, Sekikawa M, Doshita K, Miura K, Kodama H, Yabe M, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Kenmotsu H, Naito T, Murakami H, Isaka M, Ohde Y, Takahashi T. Morita M, et al. Among authors: iida y. Cancer Rep (Hoboken). 2024 Sep;7(9):e70004. doi: 10.1002/cnr2.70004. Cancer Rep (Hoboken). 2024. PMID: 39245880 Free PMC article.
Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy.
Doshita K, Tabuchi Y, Kenmotsu H, Omori S, Kawabata T, Kodama H, Nishioka N, Miyawaki E, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Kaneko T, Takahashi T. Doshita K, et al. Among authors: iida y. Adv Radiat Oncol. 2022 Nov 23;8(2):101129. doi: 10.1016/j.adro.2022.101129. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36845617 Free PMC article.
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
Wakuda K, Morita M, Sekikawa M, Morikawa N, Miura K, Doshita K, Iida Y, Kodama H, Mamesaya N, Kobayashi H, Ko R, Ono A, Kenmotsu H, Naito T, Murakami H, Muramatsu K, Kawata T, Mori K, Shimizu T, Gon Y, Takahashi T. Wakuda K, et al. Among authors: iida y. Int J Clin Oncol. 2024 Feb;29(2):96-102. doi: 10.1007/s10147-023-02451-6. Epub 2024 Jan 6. Int J Clin Oncol. 2024. PMID: 38183554
The efficacy and safety of anamorelin among patients with diabetes.
Ando K, Naito T, Hamauchi S, Miura K, Nishibori Y, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Kodama H, Yabe M, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ryo K, Wakuda K, Ono A, Kenmotsu H, Murakami H, Yamazaki K, Takahashi T. Ando K, et al. Among authors: iida y. Int J Clin Oncol. 2024 Aug;29(8):1115-1121. doi: 10.1007/s10147-024-02546-8. Epub 2024 May 9. Int J Clin Oncol. 2024. PMID: 38722487
1,188 results